Experiences of decision making about psychotropic medication during pregnancy and breastfeeding in women living with severe mental illness: a qualitative study.
Jacqueline FrayneR ElliesT NguyenPublished in: Archives of women's mental health (2023)
Findings offer understanding of patients' experiences in the decision-making and use of psychotropic medication during pregnancy and breastfeeding. Women living with severe mental illnesses, such as bipolar and psychosis, face difficult medication decisions due to uncertainty around use in pregnancy, potentially causing conflict with their dual role as both persons with a diagnosed mental illness but also new mothers. The clinician needs to provide comprehensible and concise information, giving space for a woman's voice to be heard to guide them from a position of hesitancy to one of assurance. Collaboration within a multidisciplinary team and external care providers combined with consistency of care assists this process.
Keyphrases
- mental illness
- mental health
- decision making
- healthcare
- quality improvement
- palliative care
- pregnancy outcomes
- end stage renal disease
- polycystic ovary syndrome
- preterm infants
- newly diagnosed
- ejection fraction
- adverse drug
- chronic kidney disease
- early onset
- prognostic factors
- bipolar disorder
- peritoneal dialysis
- social media
- pain management
- breast cancer risk
- preterm birth
- metabolic syndrome
- drug induced
- cervical cancer screening
- type diabetes
- patient reported